Chinese phase 2 trial finds COVID-19 vaccine is safe and induces an immune response. A phase 2 randomized controlled trial of a recombinant adenovirus type-5-vectored COVID-19 vaccine (Ad5-vectored COVID-19 vaccine) was conducted in China in April 2020 and involved more than 500 people. The primary objective of the study was to evaluate the immune response and safety of the vaccine, and to determine the most suitable dose for a phase 3 trial. Phase 3 trials are needed to confirm whether the vaccine candidate effectively protects against SARS-CoV-2 infection. Source 9z.
Three-quarters of Wuhan patients hospitalized for COVID-19 still had symptoms 6 months later, Chinese study finds. Most patients who had been hospitalized with COVID-19 still suffered a variety of symptoms - including fatigue and sleep difficulties - six months after infection, a Chinese study has found. The study of more than 1,700 patients treated in the Chinese city of Wuhan, the original epicenter of the pandemic, shows 76% suffered at least. Source 7g.
And how are the Chinese expecting us to accept that after all the secrecy and unwillingness to allow investigators in China during the start of the pandemic?
U.S. Intelligence finds China did not know about COVID-19 before outbreak, still divided over origin. U.S. Intelligence officials remain divided over the most likely origin of COVID-19, with some analysts concluding it was likely caused by natural exposure to an infected animal and others believing the first human infection was probably the result of a laboratory-associated incident, according to a summary of a new report. Source 4m.